Stryker Corp
NYSE:SYK
Stryker Corp
NYSE:SYK
Price:
324.3 USD
-0.08%
Market Closed
Updated:
May 15, 2024
P/S
Price to Sales
Price to Sales
5.9
Current
5.7
Median
2.4
Industry
Higher
than median
Higher
than industry value
Price to Sales (P/S) ratio is a valuation multiple that compares a company’s market capitalization to its revenues. It is an indicator of the value that financial markets have placed on each dollar of a company’s sales.
P/S
=5.9
Market Cap
/
123.5B
Revenue
21B
All Countries
| Market Cap | P/S | ||||
|---|---|---|---|---|---|
| US |
|
Stryker Corp
NYSE:SYK
|
123.5B USD | 5.9 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
180.9B USD | 4.5 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
136.3B USD | 18.6 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
112.1B USD | 3.5 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
108B USD | 7.3 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
67.9B USD | 3.5 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
59.2B EUR | 2.7 | |
| CN |
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
377.3B CNY | 10.5 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
52B USD | 8.5 | |
| US |
|
Dexcom Inc
NASDAQ:DXCM
|
49.9B USD | 13.1 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
43.2B USD | 11.6 |
P/S Forward Multiples
Forward P/S multiple is a version of the P/S ratio that uses forecasted revenue for the P/S calculation. 1-Year, 2-Years, and 3-Years forwards use revenue forecasts for 1, 2, and 3 years ahead, respectively.
1-Year Forward
P/S
5.5
2-Years Forward
P/S
5.1
3-Years Forward
P/S
4.8
You don't have any saved screeners yet
